Ledger Insights have reported that Moderna and IBM have partnered to explore the use of blockchain for vaccine traceability. According to the report, the pharmaceutical company, Moderna, is looking to trial this project as it would enable the authorities to see how the batches of the vaccine performs throughout its journey through supply.
This is, however, not the only partnership between the firms. The firms would also be partnering with on working on a Digital Health Pass. This development is geared towards allowing blockchain technologies to be used to instantly verify the veracity of vaccines or any test credentials.
The Vice President, North America Commercial Operations of Moderna, Michael Mullette said that, “We look forward to working with IBM to apply digital innovations to build connections between organizations, governments, and individuals to instill confidence in COVID-19 vaccines.”
IBM has also partnered with authorities in New York on how blockchain technology can be used for the purpose of improving tests and vaccines.
Authorities around the world have been actively looking at how they can infuse the use of blockchain technologies to tackle the pandemic. Air France is also actively planning to test a blockchain-based COVID-19 test verification solution for travelers that would be using its services.